Summary
The publisher's Medical Devices sector report, “Transcatheter Aortic Valve Implantation (TAVI) - Medical Devices Pipeline Assessment, 2020“. Transcatheter Aortic Valve Implantation, also known as Transcatheter Aortic Valve Replacement (TAVR), is a minimally invasive procedure used to treat severe aortic valve stenosis by implanting a Transcatheter Heart Valve in a patient's diseased aortic valve.
Note: Certain sections in the report may be removed or altered based on the availability and relevance of data in relation to the equipment type.
Scope
Reasons to Buy
The report enables you to -
The publisher's Medical Devices sector report, “Transcatheter Aortic Valve Implantation (TAVI) - Medical Devices Pipeline Assessment, 2020“. Transcatheter Aortic Valve Implantation, also known as Transcatheter Aortic Valve Replacement (TAVR), is a minimally invasive procedure used to treat severe aortic valve stenosis by implanting a Transcatheter Heart Valve in a patient's diseased aortic valve.
Note: Certain sections in the report may be removed or altered based on the availability and relevance of data in relation to the equipment type.
Scope
- Extensive coverage of the Transcatheter Aortic Valve Implantation (TAVI) under development
- The report reviews details of major pipeline products which includes, product description, licensing and collaboration details and other developmental activities
- The report reviews the major players involved in the development of Transcatheter Aortic Valve Implantation (TAVI) and list all their pipeline projects
- The coverage of pipeline products based on various stages of development ranging from Early Development to Approved / Issued stage
- The report provides key clinical trial data of ongoing trials specific to pipeline products
- Recent developments in the segment / industry
Reasons to Buy
The report enables you to -
- Formulate significant competitor information, analysis, and insights to improve R&D strategies
- Identify emerging players with potentially strong product portfolio and create effective counter-strategies to gain competitive advantage
- Identify and understand important and diverse types of Transcatheter Aortic Valve Implantation (TAVI) under development
- Develop market-entry and market expansion strategies
- Plan mergers and acquisitions effectively by identifying major players with the most promising pipeline
- In-depth analysis of the product’s current stage of development, territory and estimated launch date
Table of Contents
1 Table of Contents
2 Introduction
3 Products under Development
4 Transcatheter Aortic Valve Implantation (TAVI) - Pipeline Products under Development by Companies
5 Transcatheter Aortic Valve Implantation (TAVI) Companies and Product Overview
6 Transcatheter Aortic Valve Implantation (TAVI)- Recent Developments
7 Appendix
List of Tables
List of Figures
Companies Mentioned (Partial List)
A selection of companies mentioned in this report includes, but is not limited to:
- Aegis Surgical Limited
- Anteris Technologies Ltd
- AorTx, Inc.
- Arbor Surgical Technologies, Inc.
- Boston Scientific Corp
- Carena Healthcare Ltd
- Clemson University
- Colibri Heart Valve LLC
- Daidalos Solutions BV
- Direct Flow Medical Inc (Inactive)
- DSM Dyneema BV
- Dura LLC
- Edwards Lifesciences Corp
- Foldax Inc
- HLT, Inc.
- JC Medical, Inc.
- JenaValve Technology GmbH
- Mayo Clinic
- Medtronic Plc
- MicroPort Scientific Corp
- NVT AG
- Peijia Medical Ltd
- PolyNova Cardiovascular Inc
- RegenaGraft
- ReValve Med Inc
- SAS Cormove
- St. Jude Medical LLC
- Stony Brook University
- Symetis SA
- The University of British Columbia
- Thubrikar Aortic Valve, Inc.
- University College London
- University of California San Francisco
- University of Cambridge
- University of Iowa
- Vascular Concepts Ltd
- Venus MedTech
- Xeltis AG
